首页|芪参益气滴丸对缺血性心肌病患者左心室重构以及Hcy、NO、TNF-α、IL-6水平的影响

芪参益气滴丸对缺血性心肌病患者左心室重构以及Hcy、NO、TNF-α、IL-6水平的影响

Effects of Qishen Yiqi dropping pills on left ventricular remodelingand levels of Hcy,NO,TNF-α and IL-6 in patients with ischemic cardiomyopathy

扫码查看
目的 探讨芪参益气滴丸对缺血性心肌病患者左心室重构以及同型半胱氨酸(Hcy)、一氧化氮(NO)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)水平的影响.方法 回顾性选取2019年10月至2021年10月温州市第七人民医院门诊或住院的116例缺血性心肌病患者为研究对象,其中采取"新四联"方案(血管紧张素受体脑啡肽酶抑制剂+β受体阻滞剂+盐皮质激素受体拮抗剂+钠-葡萄糖共转运蛋白2抑制剂)常规治疗(对照组)58例,"新四联"方案联合芪参益气滴丸治疗(观察组)58例,均连续治疗 6个月.观察并比较两组患者治疗前及治疗 6个月后左心室重构指标[包括左心室后壁厚度(LVPWT)、左心室重构指数(LVRI)、左心室心肌重量指数(LVMI)]、心功能指标[包括左心室收缩末期内径(LVESd)、左心室舒张末期内径(LVEDd)、左心室射血分数(LVEF)]、实验室检测指标(包括TNF-α、IL-6、Hcy、NO)以及药物不良反应、疗效.结果 治疗6个月后两组患者LVPWT、LVRI、LVMI、LVEDd、LVESd以及血清TNF-α、IL-6、Hcy水平均低于治疗前,LVEF以及血清NO水平均高于治疗前,且观察组上述各项指标改善较对照组均更明显,差异均有统计学意义(均P<0.05).两组患者药物不良反应发生率(10.3%比15.5%)、总有效率(94.8%比86.2%)比较,差异均无统计学意义(均P>0.05).结论 芪参益气滴丸联合常规西药治疗能够明显抑制缺血性心肌病患者炎症反应,改善左心室重构和心功能,且安全性较高.
Objective To investigate the effect of Qishen Yiqi dropping pills on left ventricular remodeling and levels of homocystine(Hcy),nitric oxide(NO),tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)in patients with ischemic cardiomyopathy.Methods A retrospective study enrolled 116 patients with ischemic cardiomyopathy in outpatient or inpatient department of Wenzhou Seventh People's Hospital between October 2019 and October 2021.Among them,58 patients(control group)received conventional treatment with the"new quadruple therapy"(angiotensin receptor enkephalin inhibitor+β-blocker+mineralocorticoid receptor antagonist+sodium-glucose cotransporter 2 inhibitor)and other 58 patients(observation group)received the"new quadruple therapy"combined with Qishen Yiqi dropping pills.Both groups received continuous treatment for 6 months.The left ventricular remodeling indexes[left ventricular posterior wall thickness(LVPWT),left ventricular remodeling index(LVRI),left ventricular mass index(LVMI)],cardiac function indexes[left ventricular end-systolic diameter(LVESd),left ventricular end-diastolic diameter(LVEDd),left ventricular ejection fraction(LVEF)],laboratory indexes(TNF-α,IL-6,Hcy,NO),adverse drug reactions and curative effect in the two groups were observed and compared before and after 6 months of treatment.Results After 6 months of treatment,LVPWT,LVRI,LVMI,LVEDd,LVESd,levels of serum TNF-α,IL-6 and Hcy were decreased,while LVEF and level of serum NO were increased in both groups,and improvement of all the above indexes was more significantly in observation group than control group,the differences were statistically significant(all P<0.05).There was no significant difference in incidence of adverse drug reactions(10.3%vs.15.5%)or total response rate(94.8%vs.86.2%)between the two groups(both P>0.05).Conclusion The combination of Qishen Yiqi dripping pills with conventional western medicines can significantly inhibit inflammatory response in patients with ischemic cardiomyopathy,improve left ventricular remodeling and cardiac function indicators,and has a high level of safety.

Qishen Yiqi dripping pillIschemic cardiomyopathyLeft ventricular remodelingHomocystineNitric oxide

潘新新、吕双燕、王佩佩

展开 >

325000 温州市第七人民医院康复医疗病区

温州市人民医院检验科

芪参益气滴丸 缺血性心肌病 左心室重构 同型半胱氨酸 一氧化氮

2024

心电与循环
浙江省医学会

心电与循环

影响因子:0.269
ISSN:2095-3933
年,卷(期):2024.43(4)